72 results
Page 2 of 4
6-K
EX-99.1
c8me3wfi
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.3
sres70qqf899hr0ka
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.1
ujipyy1y
20 Apr 20
Aurinia Pharmaceuticals Inc. 6-K
9:00am
6-K
EX-99.1
9fkf 26mrplgsay3
17 Mar 20
Aurinia Pharmaceuticals Inc. 6-K
5:05pm
40-F
EX-99.3
7lybzen2
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.1
kwyeg9cepiy9t7
5 Mar 20
Annual report (Canada)
4:06pm
6-K
rpqg89a n2z
25 Feb 20
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.1
woq8jd3zrrbe6 chb
25 Feb 20
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.2
g1fbman
14 Nov 19
Current report (foreign)
4:05pm
6-K
EX-99.3
dpqmn87s817kp2
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.1
wwpmh1fpy
18 Jul 19
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.2
c6inn
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.4
xc5h5
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.1
z1wa7yy1d6oud
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
orknys4 55e2
8 Nov 18
Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
4:02pm
6-K/A
EX-99.3
980655bq5xffy9abols8
17 May 18
Current report (foreign) (amended)
12:00am
6-K
EX-99.1
f0a2s1xo548o57gp
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am
40FR12B/A
EX-99.53
ovc92pgi9yxtbxlf2
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.54
we3utz
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.55
7ggofw5300
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am